Abstract
A 52-year-old male with poorly controlled type II diabetes mellitus and presumed sarcoidosis on low-dose prednisone presented to a community hospital in North Carolina in June 2020 with diffuse skin lesions and subjective shortness of breath. A skin biopsy specimen was obtained and sent for pathological review. Bronchoscopy was performed, with no reported evidence of active infection, but no specimens were sent for diagnostic testing. He was initiated on empirical parenteral methylprednisolone for sarcoidosis. At the time of discharge (hospital day 6), he was reportedly breathing comfortably on ambient air. He was prescribed a prednisone taper along with amoxicillin-clavulanate for presumed progressive sarcoidosis with potential superimposed pneumonia.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call